NBIX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NBIX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Neurocrine Biosciences's Tax Expense for the three months ended in Sep. 2024 was $61 Mil. Neurocrine Biosciences's Pre-Tax Income for the three months ended in Sep. 2024 was $190 Mil. Therefore, Neurocrine Biosciences's Tax Rate % for the quarter that ended in Sep. 2024 was 31.79%.
The historical data trend for Neurocrine Biosciences's Tax Rate % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neurocrine Biosciences Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Tax Rate % | Get a 7-Day Free Trial | 20.43 | -281.72 | 11.64 | 27.77 | 24.81 |
Neurocrine Biosciences Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Tax Rate % | Get a 7-Day Free Trial | 28.11 | 25.48 | -25.80 | 34.08 | 31.79 |
Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.
Neurocrine Biosciences's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as
Tax Rate % | = | Tax Expense (A: Dec. 2023 ) | / | Pre-Tax Income (A: Dec. 2023 ) |
= | 82.4 | / | 332.1 | |
= | 24.81 % |
Neurocrine Biosciences's Tax Rate % for the quarter that ended in Sep. 2024 is calculated as
Tax Rate % | = | Tax Expense (Q: Sep. 2024 ) | / | Pre-Tax Income (Q: Sep. 2024 ) |
= | 60.5 | / | 190.3 | |
= | 31.79 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Neurocrine Biosciences's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.
Jude Onyia | officer: Chief Scientific Officer | C/O NEUROCRINE BIOSCIENCES, INC., 12780 EL CAMINO REAL, SAN DIEGO CA 92130 |
David W. Boyer | officer: Chief Corp. Affairs Officer | C/O NEUROCRINE BIOSCIENCES, INC., 12780 EL CAMINO REAL, SAN DIEGO CA 92130 |
William H Rastetter | director | 9885 TOWNE CENTRE DR., SAN DIEGO CA 92121 |
Ingrid Delaet | officer: Chief Regulatory Officer | C/O NEUROCRINE BIOSCIENCES, INC., 12780 EL CAMINO REAL, SAN DIEGO CA 92130 |
Matt Abernethy | officer: Chief Financial Officer | C/O NEUROCRINE BIOSCIENCES, INC., 12780 EL CAMINO REAL, SAN DIEGO CA 92121 |
Gary A Lyons | director, officer: President and CEO | 12790 EL CAMINO REAL, C/O NEUROCRINE BIOSCIENCES, SAN DIEGO CA 92130 |
Darin Lippoldt | officer: Chief Legal Officer | C/O VOLCANO CORPORATION, 3661 VALLEY CENTRE DRIVE, SUITE 200, SAN DIEGO CA 92130 |
Julie Cooke | officer: Chief Human Resources Officer | C/O NEUROCRINE BIOSCIENCES, INC., 12780 EL CAMINO REAL, SAN DIEGO CA 92130 |
Stephen A Sherwin | director | C/O CELL GENESYS, INC., 500 FORBES BLVD., SOUTH SAN FRANCISCO CA 94080 |
Leslie V Norwalk | director | C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130 |
Richard F Pops | director | 10555 SCIENCE CENTER DR, SAN DIEGO CA 92121 |
Shalini Sharp | director | C/O ULTRAGENYX PHARMACEUTICAL INC., 60 LEVERONI COURT, NOVATO CA 94949 |
Eric Benevich | officer: Chief Commerical Officer | C/O NEUROCRINE BIOSCIENCES, INC., 12790 EL CAMINO REAL, SAN DIEGO CA 92130 |
George J Morrow | director | AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799 |
Eiry Roberts | officer: Chief Medical Officer | C/O NEUROCRINE BIOSCIENCES, INC., 12780 EL CAMINO REAL, SAN DIEO CA 92130 |
From GuruFocus
By GuruFocus Research • 08-02-2024
By PRNewswire • 11-26-2024
By GuruFocus News • 10-31-2024
By PRNewswire • 09-19-2024
By GuruFocus Research • 08-02-2024
By GuruFocus News • 10-31-2024
By GuruFocus Research • 08-16-2024
By PRNewswire • 09-30-2024
By PRNewswire • 08-28-2024
By GuruFocus News • 10-17-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.